FundedIQ
Biotechnology

PAQ Therapeutics: Funding, Investors & Team (Oct 2026)

PAQ Therapeutics is a biotechnology company that is at the forefront of developing a different method to improve health and treat illness by harnessing the power of autophagy, the body's highly adaptable process for breaking down cells naturally.

www.paqtx.com LinkedIn Cambridge, United States 1-10 employees
Total raised
$107M
Rounds
3
Latest
Series B
Jan 2026

PAQ Therapeutics has raised $107M across 3 funding rounds on record, the most recent a Series B of $38.0M announced in Jan 2026.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

PAQ Therapeutics Company Profile and Key Stats

Total funding raised
$107M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series B
$38.0M in Jan 2026
Employees
1-10
reported band
Headquarters
Cambridge, United States

Latest funding round on record: Jan 2026.

PAQ Therapeutics Funding Rounds

Date
Round
Amount
Series B
$38.0M
Series B
$39.0M
Series A
$30.0M

PAQ Therapeutics raised $30.0M in a Series A announced in Jul 2021.

3.8 years later, a Series B of $39.0M was announced in May 2025.

8 months later, a Series B of $38.0M was announced in Jan 2026.

PAQ Therapeutics Founders and Leadership Team

Name
Role
Contact
Boxun Lu
Founder
—
Nan Ji
CEO
—

No contact details are on record for this team yet.

PAQ Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
4,422
$32M

PAQ Therapeutics' latest round of $38.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like PAQ Therapeutics in Biotechnology and Cambridge

Companies Similar to PAQ Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

PAQ Therapeutics Funding FAQs

What does PAQ Therapeutics do?

PAQ Therapeutics is a biotechnology company that is at the forefront of developing a different method to improve health and treat illness by harnessing the power of autophagy, the body's highly adaptable process for breaking down cells naturally.

How much funding has PAQ Therapeutics raised?

PAQ Therapeutics has raised $107M across 3 rounds on record. The most recent is a Series B of $38.0M announced in Jan 2026.

When did PAQ Therapeutics last raise funding?

PAQ Therapeutics' most recent funding round on record is a Series B of $38.0M, announced in Jan 2026.

Who founded PAQ Therapeutics?

FundedIQ lists Boxun Lu (Founder) at PAQ Therapeutics.

Who is the CEO of PAQ Therapeutics?

Nan Ji is listed as CEO at PAQ Therapeutics.

Where is PAQ Therapeutics headquartered?

PAQ Therapeutics is based in Cambridge, Massachusetts, United States.

How many employees does PAQ Therapeutics have?

PAQ Therapeutics is in the 1-10 employee band.

How does PAQ Therapeutics' funding compare to other Biotechnology startups?

PAQ Therapeutics' latest round of $38.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's PAQ Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PAQ Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.